Risvutatug Rezetecan (a B7-H3-Directed ADC) Versus Topotecan in Relapsed SCLC: Primary Results of Phase 3 ARTEMIS-008
J. Wang1, L. Wang2, J. Duan1, H. Liu3, Q. Wang4, H. Wang2, L. Sun5, S. Huang6, Y. Huang7, F. Tong8, W. Zheng9, T. Chu10, Y. Fan11, D. Huang12, P. Zhang13, W. Guo14, B. Liu15, J. Zhou16, Q. Li17, Y. Dong18, Q. Liu18, M. Zhang18, X. Zhang18, J. Yu2
